Literature DB >> 30891134

Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists.

Aniket Magarkar1, Gisela Schnapp1, Anna-Katharina Apel1, Daniel Seeliger1, Christofer S Tautermann1.   

Abstract

The target residence time (RT) for a given ligand is one of the important parameters that have to be optimized during drug design. It is well established that shielding the receptor-ligand hydrogen bond (H-bond) interactions from water has been one of the factors in increasing ligand RT. Building on this foundation, here we report that shielding an intra-protein H-bond, which confers rigidity to the binding pocket and which is not directly involved in drug-receptor interactions, can strongly influence RT for CCR2 antagonists. Based on our recently solved CCR2 structure with MK-0812 and molecular dynamics (MD) simulations, we show that the RT for this and structurally related ligands is directly dependent on the shielding of the Tyr120-Glu291 H-bond from the water. If solvated this H-bond is often broken, making the binding pocket flexible and leading to shorter RT.

Entities:  

Year:  2019        PMID: 30891134      PMCID: PMC6421533          DOI: 10.1021/acsmedchemlett.8b00590

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  29 in total

1.  Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.

Authors:  K J Katschke; J B Rottman; J H Ruth; S Qin; L Wu; G LaRosa; P Ponath; C C Park; R M Pope; A E Koch
Journal:  Arthritis Rheum       Date:  2001-05

2.  Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design.

Authors:  Peter Schmidtke; F Javier Luque; James B Murray; Xavier Barril
Journal:  J Am Chem Soc       Date:  2011-10-28       Impact factor: 15.419

Review 3.  Drug-target residence time and its implications for lead optimization.

Authors:  Robert A Copeland; David L Pompliano; Thomas D Meek
Journal:  Nat Rev Drug Discov       Date:  2006-08-04       Impact factor: 84.694

4.  Pathway and mechanism of drug binding to G-protein-coupled receptors.

Authors:  Ron O Dror; Albert C Pan; Daniel H Arlow; David W Borhani; Paul Maragakis; Yibing Shan; Huafeng Xu; David E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-21       Impact factor: 11.205

Review 5.  Molecular determinants of drug-receptor binding kinetics.

Authors:  Albert C Pan; David W Borhani; Ron O Dror; David E Shaw
Journal:  Drug Discov Today       Date:  2013-02-27       Impact factor: 7.851

Review 6.  The chemokine superfamily revisited.

Authors:  Albert Zlotnik; Osamu Yoshie
Journal:  Immunity       Date:  2012-05-25       Impact factor: 31.745

Review 7.  Pharmacological modulation of chemokine receptor function.

Authors:  D J Scholten; M Canals; D Maussang; L Roumen; M J Smit; M Wijtmans; C de Graaf; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 8.  Chemokine receptor antagonists: overcoming developmental hurdles.

Authors:  Richard Horuk
Journal:  Nat Rev Drug Discov       Date:  2008-12-12       Impact factor: 84.694

Review 9.  A medicinal chemist's guide to molecular interactions.

Authors:  Caterina Bissantz; Bernd Kuhn; Martin Stahl
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

10.  Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis.

Authors:  Christian Vestergaard; Helle Just; Jane Baumgartner Nielsen; Kristian Thestrup-Pedersen; Mette Deleuran
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

View more
  2 in total

Review 1.  How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.

Authors:  Mariona Torrens-Fontanals; Tomasz Maciej Stepniewski; David Aranda-García; Adrián Morales-Pastor; Brian Medel-Lacruz; Jana Selent
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 2.  The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.

Authors:  Attila Egyed; Dóra Judit Kiss; György M Keserű
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.